MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02922nam a22003857a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
SNU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20160926140407.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160413b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780123820303 |
| 028 ## - Distributer Name & Address |
|---|
| Distributor Name |
Global Information Systems Technology Pvt Ltd |
| Distributor Address |
877, Udhyog Vihar, Phase-V, Gurgaon |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1 SIL |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Silverman, Richard B., |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
The organic chemistry of drug design and drug action. |
| Remainder of title |
Third edition / |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Amsterdam ; |
| Name of publisher, distributor, etc |
Academic Press, an imprint of Elsevier, |
| Date of publication, distribution, etc |
©2014 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 517 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
24 cm. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 1 - Introduction, In The Organic Chemistry of Drug Design and Drug Action |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000015 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 2 - Lead Discovery and Lead Modification, |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000027 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 3 - Receptors, In The Organic Chemistry of Drug Design and Drug Action |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000039 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 4 - Enzymes, In The Organic Chemistry of Drug Design and Drug Action |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000040 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 5 - Enzyme Inhibition and Inactivation, |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000052 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 6 - DNA-Interactive Agents, |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000064 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 7 - Drug Resistance and Drug Synergism, |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000076 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 8 - Drug Metabolism, |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B9780123820303000088 |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 9 - Prodrugs and Drug Delivery Systems, |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/article/pii/B978012382030300009X |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Abstract : Provides a basis and overall context for concepts introduced and discussed in more detail in subsequent chapters in this book. An historical context is given to the topic of drug discovery, followed by a high level overview of modern approaches to rational drug design. The approaches and steps typically encountered in modern rational drug design, including target identification, lead discovery, and lead modification, are introduced, and an overview of the subsequent steps required for drug development prior to regulatory approval, such as pharmacokinetics, preclinical studies, clinical trials, and intellectual property issues, are summarized. |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/book/9780124186910 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Bioorganic chemistry. |
| Source of heading or term |
|
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical chemistry. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Molecular pharmacology. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Design. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
E-Books |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Holladay, Mark W., |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
E-Book |
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/book/9780123820303 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Electronic Resources (E-Books) |
